13. Antimicrobial Management of Patients with Fever and Neutropenia Following Hematopoietic Stem Cell Transplantation

  1. Deepali Kumar MD, MSc, FRCPC and
  2. Atul Humar MD, MSc, FRCPC
  1. Upton D. Allen MBBS, MSc, FAAP, FRCPC, FRCP (UK)1,2

Published Online: 5 MAY 2011

DOI: 10.1002/9781444397949.ch13

The AST Handbook of Transplant Infections

The AST Handbook of Transplant Infections

How to Cite

Allen, U. D. (2011) Antimicrobial Management of Patients with Fever and Neutropenia Following Hematopoietic Stem Cell Transplantation, in The AST Handbook of Transplant Infections (eds D. Kumar and A. Humar), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444397949.ch13

Editor Information

  1. Transplant Infectious Diseases, University of Alberta, Edmonton, Canada

Author Information

  1. 1

    Departments of Paediatrics and Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada

  2. 2

    Infectious Diseases, The Hospital for Sick Children, Toronto, Canada

Publication History

  1. Published Online: 5 MAY 2011
  2. Published Print: 13 MAY 2011

ISBN Information

Print ISBN: 9780470658277

Online ISBN: 9781444397949

SEARCH

Keywords:

  • antimicrobial management of patients - with fever and neutropenia, after hematopoietic stem cell transplantation;
  • stepwise approach to empiric antimicrobial therapy - in febrile neutropenia;
  • anti-pseudomonal beta-lactam (piperacillin-tazobactam) aminoglycoside;
  • reassessing duration of antimicrobial therapy;
  • ANC, absolute neutrophil count;
  • CT, computed tomography;
  • vancomycin use - indicated in severe mucositis;
  • agents for empiric antifungal therapy - in febrile neutropenia;
  • lipid amphotericn B products - amphotericin B lipid complex;
  • HSCT, hematopoietic stem cell transplant

Summary

This chapter contains sections titled:

  • Stepwise approach to empiric antimicrobial therapy in febrile neutropeniaa

  • Agents for empiric antifungal therapy in febrile neutropenia